KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 128 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $44,393 | +12.5% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $39,465 | +1.0% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $39,083 | +38.8% | 2,250 | +12.5% | 0.00% | – |
| Q2 2023 | $28,160 | +30.9% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,520 | -28.2% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $29,960 | +15.2% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +36.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -5.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +4.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -17.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q1 2021 | $74,040,000 | +411233.3% | 4,000 | +300.0% | 0.00% | – |
| Q4 2020 | $18,000 | +125.0% | 1,000 | +100.0% | 0.00% | – |
| Q3 2020 | $8,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 30,000 | $560,100 | 0.52% |
| ADIRONDACK TRUST CO | 875 | $16,266 | 0.01% |
| CWM, LLC | 451 | $8 | 0.00% |
| BARCLAYS PLC | 34,839 | $650 | 0.00% |
| OSAIC HOLDINGS, INC. | 623 | $11,631 | 0.00% |